Analystreport

Conatus Pharmaceuticals (NASDAQ: CNAT) had its price target lowered by analysts at SunTrust Banks, Inc. to $4.30.

CONATUS PHARMACEUTICALS INC  (CNAT) 
Last conatus pharmaceuticals inc earnings: 11/5 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.conatuspharma.com/investor-relations